Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
3
33%
Ph not_applicable
6
67%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
3(33.3%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (33.3%)
N/A6 (66.7%)

Trials by Status

terminated111%
completed667%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9